HAE: Haemonetics Company P/E multiplikatori

Haemonetics Company (HAE) korporativ emblemasi va logotipi

Robotlashtirilgan steril yig'ish liniyalari nuqsonlarni minimallashtiradi, buni GURU.Markets platformasi grafigidagi Haemonetics Corporation (HAE) kompaniyasining P/E tarixidan ko'rish mumkin, u yerda 52.70 darajasi yangi qiymatlarni qayd etmoqda. Ekologik rivojlanish vektori ishlab chiqarishning uglerod izini kamaytiradi, hematologiya sohasidagi yetakchi sifatidagi benuqson imij esa Haemonetics Corporation texnologiyalarining xavfsizligiga global ishonchni kafolatlaydi.

HAE: Haemonetics P/E multiplikatori 04.07.2022 - 12.11.2026

Haemonetics Corp. (HAE) kompaniyasining tahliliy kesimlari

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning har tomonlama tahlili:HAE haemonetics.com
Haemonetics Company brend mahsuloti

P/E koeffitsiyenti foydaning bir birligining bozor qiymatini belgilaydi, bu esa investorga aktivning haqiqiy daromadlariga nisbatan haddan tashqari qimmat baholanganlik darajasini yoki uning potentsial past baholanganligini baholash imkonini beradi. Haemonetics Corporation (HAE) kompaniyasining narx-foyda koeffitsiyentini tahlil qilishda, ishlab chiqarish quvvatlaridan to'liq foydalanish va ishlab chiqarish liniyalarini modernizatsiya qilishni hisobga olish muhimdir, bu esa biznesning fundamental barqarorligini tasdiqlaydi va narxlarning keskin korreksiyasi xavflarini minimallashtiradi.

Muhim raqobatchilar

Kapitalizatsiyaning foydaga nisbati dexcom.com DXCM|Narx-foyda koeffitsiyenti PEN (Penumbra)|P/E multiplikatori Novanta Inc (NOVT)|Inspire Sleep - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati PRCT (Procept)|CONMED Corporation - P/E multiplikatori|Biznesning o‘zini qoplash muddati pulsebiosciences.com PLSE|INMD: P/E multiplikatori|Narx-foyda koeffitsiyenti Picard Medical Corp|Narx-foyda koeffitsiyenti SRDX|SENS: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati NeuroPace, Inc. (NPCE)|Narx-foyda koeffitsiyenti tactilemedical.com TCMD|P/E multiplikatori SNWV (SANUWAVE)|Outset Medical Inc (OM) - Kapitalizatsiyaning foydaga nisbati|Electromed Inc - P/E multiplikatori|LNSR (LENSAR Inc) - Narx-foyda multiplikatori|RCEL: P/E multiplikatori|PROF - Biznesning o‘zini qoplash muddati|BDMD (Baird Medical Investment Holdings) - P/E multiplikatori|Narx-foyda koeffitsiyenti EDAP Medical (EDAP)|P/E multiplikatori APYX|P/E multiplikatori icecure-medical.com (ICCM)|Narxning foydaga nisbati Pulmonx LUNG|TELA Bio Inc. - Narxning foydaga nisbati|CTSO: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati SRTS (Sensus Healthcare Inc)|ZYXI: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati electroCore (ECOR)|Narxning foydaga nisbati Vicarious Surgical Inc|IINN - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narx-foyda koeffitsiyenti ICU (SeaStar Medical)|P/E multiplikatori iridex.com (IRIX)|P/E multiplikatori INBS (Intelligent Bio Solutions Inc.)|Biznesning o‘zini qoplash muddati Beyond Air Inc (XAIR)|PFSA - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati SSKN|GlucoTrack, Inc. (GCTK) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti nanovibronix.com|VERO (Venus Concept Corp) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Nuwellis Corp NUWE|Narxning foydaga nisbati Aethlon Medical (AEMD)|asensus.com - Narx-foyda multiplikatori|Avinger - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati BSGM (Biosig Technologies)|Cutera, Inc - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati KNW (Know Labs Corporation)|NARI: P/E multiplikatori|nevro.com (NVRO) - P/E multiplikatori|RSLS (ReShape Lifesciences, Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Silk Road Medical, Inc. SILK